Allgens Medical Technology (688613.SH): Qilun Tianyou plans to reduce its holdings by no more than 400,000 shares of the company.

Allgens Medical Technology (688613.SH) announced that, due to its own funding needs, shareholder Beijing Qilun Tianyou Venture Capital Co., Ltd. ("Qilun Tianyou") plans to reduce its holdings of the company's shares through centralized bidding or block trades. Qilun Tianyou intends to reduce its holdings by no more than 400,000 shares, accounting for 0.29% of the company's total shares. The above reduction plan will be implemented within 3 months after 15 trading days from the date of announcement disclosure. Through centralized bidding, the total number of shares reduced within any consecutive 90 natural days shall not exceed 1% of the company's total shares.